Transgenic overexpression of caveolin-3 in skeletal muscle fibers induces a Duchenne-like muscular dystrophy phenotype

被引:123
作者
Galbiati, F
Volonté, D
Chu, JB
Li, M
Fine, SW
Fu, MF
Bermudez, J
Pedemonte, M
Weidenheim, KM
Pestell, RG
Minetti, C
Lisanti, MP
机构
[1] Yeshiva Univ Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA
[2] Yeshiva Univ Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10461 USA
[3] Yeshiva Univ Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA
[4] Yeshiva Univ Albert Einstein Coll Med, Dept Neuropathol & Pathol, Bronx, NY 10461 USA
[5] Yeshiva Univ Albert Einstein Coll Med, Albert Einstein Canc Ctr, Bronx, NY 10461 USA
[6] Univ Genoa, Ist Gastlili, Serv Malattie Neuromuscolari, I-16147 Genoa, Italy
关键词
D O I
10.1073/pnas.160249097
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
It recently was reported that Duchenne muscular dystrophy (DMD) patients and mdx mice have elevated levels of caveolin-3 expression in their skeletal muscle. However, it remains unknown whether increased caveolin-3 levels in DMD patients contribute to the pathogenesis of DMD. Here, using a genetic approach, we test this hypothesis directly by overexpressing wild-type caveolin-3 as a transgene in mice, Analysis of skeletal muscle tissue from caveolin-3- overexpressing transgenic mice reveals: (i) a dramatic increase in the number of sarcolemmal muscle cell caveolae; (ii) a preponderance of hypertrophic, necrotic, and immature/regenerating skeletal muscle fibers with characteristic central nuclei; and (iii) down-regulation of dystrophin and beta-dystroglycan protein expression. In addition, these mice show elevated serum creatine kinase revels, consistent with the myo-necrosis observed morphologically. The Duchenne-like phenotype of caveolin-3 transgenic mice will provide an important mouse model for understanding the pathogenesis of DMD in humans.
引用
收藏
页码:9689 / 9694
页数:6
相关论文
共 49 条
  • [1] Atm-deficient mice: A paradigm of ataxia telangiectasia
    Barlow, C
    Hirotsune, S
    Paylor, R
    Liyanage, M
    Eckhaus, M
    Collins, F
    Shiloh, Y
    Crawley, JN
    Ried, T
    Tagle, D
    WynshawBoris, A
    [J]. CELL, 1996, 86 (01) : 159 - 171
  • [2] BONILLA E, 1981, AM J PATHOL, V104, P167
  • [3] X-CHROMOSOME-LINKED MUSCULAR-DYSTROPHY (MDX) IN THE MOUSE
    BULFIELD, G
    SILLER, WG
    WIGHT, PAL
    MOORE, KJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (04): : 1189 - 1192
  • [4] CHANG HW, 1989, J BIOL CHEM, V264, P20831
  • [5] Motor dysfunction in a mouse model for Down syndrome
    Costa, ACS
    Walsh, K
    Davisson, MT
    [J]. PHYSIOLOGY & BEHAVIOR, 1999, 68 (1-2) : 211 - 220
  • [6] Molecular and cellular biology of caveolae - Paradoxes and plasticities
    Couet, J
    Li, SW
    Okamoto, T
    Scherer, PE
    Lisanti, MP
    [J]. TRENDS IN CARDIOVASCULAR MEDICINE, 1997, 7 (04) : 103 - 110
  • [7] Caveolin-3 is not an integral component of the dystrophin glycoprotein complex
    Crosbie, RH
    Yamada, H
    Venzke, DP
    Lisanti, MP
    Campbell, KP
    [J]. FEBS LETTERS, 1998, 427 (02) : 279 - 282
  • [8] Chromosomal localization, genomic organization, and developmental expression of the murine caveolin gene family (Cav-1, -2, and -3) - Cav-1 and Cav-2 genes map to a known tumor suppressor locus (6-A2/731)
    Engelman, JA
    Zhang, XL
    Galbiati, F
    Lisanti, MP
    [J]. FEBS LETTERS, 1998, 429 (03) : 330 - 336
  • [9] Molecular genetics of the caveolin gene family:: Implications for human cancers, diabetes, Alzheimer disease, and muscular dystrophy
    Engelman, JA
    Zhang, XL
    Galbiati, F
    Volonté, D
    Sotgia, F
    Pestell, RG
    Minetti, C
    Scherer, PE
    Okamoto, T
    Lisanti, MP
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 63 (06) : 1578 - 1587
  • [10] Recombinant expression of caveolin-1 in oncogenically transformed cells abrogates anchorage-independent growth
    Engelman, JA
    Wykoff, CC
    Yasuhara, S
    Song, KS
    Okamoto, T
    Lisanti, MP
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (26) : 16374 - 16381